Bovenkamp is one of the most vocal opponents challenging patients as stakeholders in clinical guideline development.[38] Adonis is more positive in her shorter paper.[39] Caron-Flinterman goes into more detail in her dissertation.[40] She is cited in a more recent open-access survey laying out researchers' various views, especially on the ethical dimensions of engaging patients as partners within research teams.[41]